1Svitiz WI. Lipotoxicity and glulotocicity in type 2 diabetes:Effects on development and progression[J].Postgrad Med,2001,109(1) : 55- 59 ;63- 64
2Garvey WT, Olefsky IM, Griffin J, et al. The effect of insulin treatment on insulin Secretion and insulinaction in type Ⅱ diabetes mellitus[J]. Diabetes, 1985,34(2) :222 - 234
1Weyer. Dificiency in AIR predict IGT and Type 2 diabetes. Diabetes Care, 2001,24 : 89-94.
2Haffner SM, Miettinen H, Gaskill SP, et al. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes, 1995,44: 1386-1391.
3Bruce DG, Chisholm DJ, Leonare H, et al. Physiological importance of deficiency in early prandial insulin secretion in non-in-sulin-dependent diabetes. Diabetes, 1988,37: 736-743.
4Bruttomesso D, Pianta A, Mari A, et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes, 1999,48: 99-105.
5Ilkova H, glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20:1353-1356.
6Walton C, Godsland IF, Proudler AJ, et al. Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in nonobese healthy men. J Clin Endocrinol Metab,1992,75: 170-175.
7Purrello F, Rabuazza AM. Metabolic factors that affect betacell function and survival. Diabet Nutr Metab, 2000, 13: 84-91.
8Sivitz WI. Lipotoxieity and glueotoxieity in type 2 diabetes. Effects on development and progression. Postgrad Med, 2001,109: 55-59,63-64.
9Lenhard M J, Reeves GD. Continous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med,2001,161: 2293-2300.
10Dupuy O, Mayaudon H, Palou M, et al. Optimized transient insulin infusion in uneontrolled type 2 Diabetes : Evaluation of a pragmatie attitude. Diabet Med, 2000,26 : 371-375.
4Intensive blood - glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes ( UKPDS 33 ). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;Sep 12;352(9131):837 - 53.
5Banerji MA. Long - term normoglycernic remission in black newly diagnosed N1DDM subjects. Diabetes 1996 ; Mar ;45 ( 3 ) : 337 -41.
6Yanbing Li MD, Wen Xu MD, Zhihong Liao MD & PhD Bin Yao MD, Xiahua Chen MD, Zhimin Huang MD, Guoliang Hu MD and Jianping Weng MD & PhD. Induction of Long - term Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients is Associated with Improvement of Beta - cell Function. Diabetes Care 2004 ; 27 ( 11 ) :2957 -2602.
7Henry RR. Glucose control and insulin resistance in non - insulin -dependent diabetes mellitus. Ann intern Med 1996;124:97 - 103.
